Clinical Trials Logo

Clinical Trial Summary

Evaluating the neurologic prognosis in disorders of consciousness (DOC) patients is still a crucial issue in intensive care units. Neurophysiology allows the investigators to record cerebral responses of patients to auditory stimuli and in particularly to their own name. Numerous studies try to improve the relevance of the auditory stimuli used in this paradigm. Here the investigators assess if the use of own name stimuli uttered by more expressive voices (for example smiling voices) modulates the cerebral responses recorded. They then correlate these cerebral responses to the neurologic prognosis at three months.


Clinical Trial Description

Late auditory evoked potentials (as P3 wave) are used in neurophysiology to assess the level of consciousness in DOC (disorder of consciousness) patients. The P3 wave, elicited by listening standard and deviant stimuli, corresponds to the activation of a frontoparietal network and is considered to reflect a cognitive attention task. Using the own name of the patient as deviant stimuli improve the ability to detect the P3 wave because of the particularly relevance of this stimulus for the patient. However the correlation of this P3 wave and neurologic prognosis is still imperfect and depends on the etiology of the DOC. In human cognition, to identify the expressivity valence of a voice is essential. Neural processing of expressive voices involves more widespread brain areas than neutral voices processing. Here the investigators assume that using own name stimuli uttered by more expressive voices (positive : smiling voice or negative : rough voice) should recruit more widespread brain areas and modulate the cerebral responses recorded. The investigators then evaluate if these cerebral responses are relevant markers of consciousness and correlate them to neurologic prognosis at three months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04798508
Study type Interventional
Source Centre Hospitalier St Anne
Contact Estelle Pruvost-Robieux, MD
Phone + 33 1 45 65 81 89
Email e.pruvost@ghu-paris.fr
Status Recruiting
Phase N/A
Start date July 30, 2020
Completion date October 30, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05527080 - Development of Motility and Cognition in Infants
Active, not recruiting NCT04108728 - Neuropsychological Development and Executive Functioning of Children Born to HIV- Infected Mothers ( NEUROPSY-HEU ) N/A
Not yet recruiting NCT05962281 - Investigation The Effect of Conventional Vs. Individualized tDCS Intensity to Achieve Uniform E-Fields N/A
Completed NCT03145987 - Effects of a Food Supplement on Cognitive and Neuropsychological Functioning in Older Adults. N/A
Completed NCT04052178 - Sensory Neuromodulation Protocol for the Treatment of Post-stroke Oropharyngeal Dysphagia. N/A
Completed NCT05311852 - Effects of PEA-LUT on Frontal Lobe Functions and GABAergic Transmission in Long-Covid Patients N/A
Completed NCT03401307 - Central and Peripheral Nervous System Changes as Markers of Disease Progression in Multiple Sclerosis
Recruiting NCT05846958 - Efficacy of Laser Acupuncture on Neurophysiological Parameters of Median Nerve in Postpartum Women N/A